{"id":440133,"date":"2021-02-19T16:03:22","date_gmt":"2021-02-19T21:03:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=440133"},"modified":"2021-02-19T16:03:22","modified_gmt":"2021-02-19T21:03:22","slug":"constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/","title":{"rendered":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">\n        <strong>CAMBRIDGE,\u00a0Mass., Feb.  19, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AdfgyyzPRvv_bZ5OUK9frduzNse5gZGKN_EgDKAAtp1RX505KuHhtDlxqc9aQbaQNkNdf32REDF_HeTOsHcuXvZ8Ty10IWlQPOnXljhMHbEnXX5gkxO7pB5IXN5rH-KE\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Constellation Pharmaceuticals<\/a>, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the 10<sup>th<\/sup> Annual SVB Leerink Global Healthcare Conference at 3:40 PM EDT on February 26. Live audio webcast of Mr. Raythatha\u2019s presentations and archives for replay will be available on the Investor Relations section of Constellation\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vip7Drb1Veqh2iuWG5exkHhnTxEr0ytFmgMVOsE7sRjpRNa1AlHsQIAAc-k5gqJX30Cj1slCcUqMLentWkb6K7xaoZ6KSa0wWn7XqLr1EO31MZmJQxRvECACQwNFzn_HvWgXgTOREPxQeouocWDs4khu0PIe2tSruxPM51by3AwWR7G11_R5XCY79ek8ebHH6vLG5bUccGdon3zYZC6qiA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/ir.constellationpharma.com\/events-and-presentations\/events<\/a>. The audio webcast replays will be available for 90 days following the live presentation.<\/p>\n<p>\n        <strong>About Constellation Pharmaceuticals<\/strong>\n      <\/p>\n<p>Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is driving development of the BET inhibitor pelabresib<em> (<\/em>CPI-0610) for the treatment of myelofibrosis as well as its EZH2 inhibitor CPI-0209 for the treatment of other cancers. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative small-molecule product candidates.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Kia Khaleghpour, Ph.D.<br \/>Vice President, Investor Relations and Communications<br \/>Constellation Pharmaceuticals<br \/>+1 617-844-6859<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5CMq87P8KSrFfJ2maNIset42PBvnW43ZGmCAXlqwAoDz6wikTzO4U1YoTs5yajAyP09JdKHsjS0iqyC2n8VMiCpD5TvKb-FrFQkp__Oubpz_bNXcQwXa47WhC9F7YprvOJsWK2HWBDPs0pKFTqghFw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">kia.khaleghpour@constellationpharma.com<\/a><\/p>\n<p>Lauren Arnold<br \/>Media Relations<br \/>MacDougall Biomedical Communications<br \/>+1 781-235-3060<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5tC2E31pYBF8f9YdZK1PkRdPpvAZCq_c8Wz-Xld7K0rftyR5Z0wB3PWA4ohBjJoLlmpk2uxLDzzI2xfVWxIXTeUEbDzZ1UcoDjDyY9RGgZc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">larnold@macbiocom.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/1b3e21c0-9b25-49aa-ba56-58ec6c80786d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE,\u00a0Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 PM EDT on February 26. Live audio webcast of Mr. Raythatha\u2019s presentations and archives for replay will be available on the Investor Relations section of Constellation\u2019s website at http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replays will be available for 90 days following the live presentation. About Constellation Pharmaceuticals Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-440133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE,\u00a0Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 PM EDT on February 26. Live audio webcast of Mr. Raythatha\u2019s presentations and archives for replay will be available on the Investor Relations section of Constellation\u2019s website at http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replays will be available for 90 days following the live presentation. About Constellation Pharmaceuticals Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious &hellip; Continue reading &quot;Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T21:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference\",\"datePublished\":\"2021-02-19T21:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/\",\"name\":\"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\",\"datePublished\":\"2021-02-19T21:03:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk","og_description":"CAMBRIDGE,\u00a0Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 PM EDT on February 26. Live audio webcast of Mr. Raythatha\u2019s presentations and archives for replay will be available on the Investor Relations section of Constellation\u2019s website at http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replays will be available for 90 days following the live presentation. About Constellation Pharmaceuticals Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious &hellip; Continue reading \"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-19T21:03:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference","datePublished":"2021-02-19T21:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/","name":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=","datePublished":"2021-02-19T21:03:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ3MCMzOTg2MjcxIzIxMjA4NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-participate-in-the-10th-annual-svb-leerink-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=440133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=440133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=440133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=440133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}